Amrutanjan Healthcare has informed that a meeting of the Board of Directors is scheduled to be held on Thursday, November 9, 2017 at the registered office of the Company to consider and approve the Un-audited Financial Results along with the Limited Review Report for the quarter and half year ended September 30, 2017; and declaration of 1st interim dividend for the financial year 2017-18.
The above information is a part of company’s filings submitted to BSE.